CNO vs ENVA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CNO presents a conflicting profile: while the company demonstrates a strong track record of earnings beats and a stable Piotroski F-Score of 4/9, it is currently trading at a significant premium to its Intrinsic Value ($16.10) and Graham Number ($38.01). The valuation is supported by a low forward P/E of 8.92, but this is offset by a highly bearish technical trend (10/100) and aggressive insider selling. Overall, the strong operational performance is currently decoupled from the deteriorating insider sentiment and technical momentum.
With a Piotroski F-Score of 4/9 (Stable) and a current price of $166.65 positioned between the Graham Number ($124.67) and a high Intrinsic Value ($362.26), ENVA presents a strong value-growth opportunity. The company demonstrates exceptional fundamental momentum with YoY earnings growth of 28.6% and a highly attractive forward P/E of 8.67. While insider sentiment is bearish and technical trends are currently weak, the high ROE (25.13%) and a long track record of earnings beats provide a significant safety margin. The high debt-to-equity ratio is typical for the credit services industry and is mitigated by an exceptionally strong current ratio of 22.71.
Compare Another Pair
Related Comparisons
CNO vs ENVA: Head-to-Head Comparison
This page compares CNO Financial Group, Inc. (CNO) and Enova International, Inc. (ENVA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.